|
Products
Critical Care Division Netilmicin Sulfate Injection USP 50, 100, 200 and 300 mg U-Azom (Aztreonam 1gm Vial and 500 gm Vial) Piperacillin And Tazobactam For Injection 2.25g and 4.5g Amphotin - Lip 10mg Amphotericin B Lipid Complex Injection 50 Mg Amphotericin B Lipid Complex Injection 100 mg Cefoprim 250mg Cefoprim (Cefuroxime Axetil Tablets USP 500 mg) Cefoprim 750mg Cefoprim (Cefuroxime Sodium For Injection USP 1.5 g) Clavox 1.2g Clavox Clinzucia 600mg Clinzucia 150mg Clinzucia (Clindamycin 300mg Injection) Clinzucia (Clindamycin 300mg Cap.) Egytig 50mg Epime 1g Epime - TZ (Cefepime 1000 mg - Tazobactam 125 mg) Forzid 1g Forzid (Ceftazidime For Injection USP 2.0 G) Heprotec 5g Heprotec 5g / 10ml Heprotec 150mg Kephazon 2GM Kephazon 1GM Kephazon-S 2GM Kephazon-S (Cefoperazone And Sulbactam 1G) Kephazon-S Forte 3GM Kephazon-S Forte 1.5G Laczucia 200MG Laczucia (Lactulose 100MG Bottles) Menem 1G Menem (Meropenem For Injection USP 500 MG) Mucosys 600MG Mucosys 5ML Mucosys 2ML Noralin 2ML (2MG/ML) SOL - U- PRED (Methylprednisolone Sodium Succinate 1G Vial) Solupred Tecazi 500MG Tecazi 250MG Tecoplan 400MG Tecoplan (Teicoplanin For Injection 200 MG Lyophilized) Ticarnic Tocin 80MG U-Aminos (Dialysis Sparing Amino Acid Tablets) Unicalcin 50 IU Unicalcin 100 IU Unicalcin (Calcitonin Salmon Injection USP 50 IU) Unipol-B 500000 Units Unitrax-s (Ceftriaxone And Sulbactam For Injection 1.5 G) Univir 250MG Vancotec CP 500mg Vancotec CP (Vancomycin Hydrochloride For Injection USP 1G) Specialty Division Oncology Division Copas Division Hygea Division Rinon Division Pharmaceutical Products Pharmaceutical Injectables
 |
|
Clients can avail from us a range of Critical Care Division medicines. Our medicines are widely used in the treatment of several severe diseases such as anesthesia, infections and several other diseases. These are also used for treating as well as prevention of cancer. Clients are offered these medicines at highly reasonable prices. We offer Acetylcysteine Solution USP 20% 2 ml and Amoxicillin and Clavulanate Potassium Injection USP 0.6 g in this range.
|
Netilmicin Sulfate Injection USP 50, 100, 200 and 300 mg
 | Indications :
-
Complicated UTI -
Septicemia -
Skin & Soft tissue infections -
Intra-abdominal infections -
Lower respiratory tract infections
Dosage : Adult Dose : 4.0 to 6.0 mg/kg/day as TID / BID
Paediatric Dose : 6.0 to 7.5 mg/kg/day.
Renally Impaired Patients : The initial dose is the same as that recommended for patients with normal renal function. | CrCl Rate (mL/min/1.73m2) | Percent of Usua Dose | | >100 | 100 | | 70-100 | 80 | | 55-70 | 65 | | 45-55 | 55 | | 40-45 | 50 | | 35-40 | 40 | | 30-35 | 35 | | 25-30 | 30 | | 20-25 | 25 | | 15-20 | 20 |
Packing : | 50 mg | 1 Ampoules of 2 ml | | 100 mg | 1 Ampoules of 2 ml | | 200 mg | 1 Ampoules of 2 ml | | 300 mg | 1 Ampoules of 3 ml | |
U-Azom (Aztreonam 1gm Vial and 500 gm Vial)
Indications :
-
Intra-abdominal infections. -
Urinary Tract Infections. -
Septicemia. -
Lower Respiratory Tract Infections -
Skin and soft tissue Infections. -
Bone and joint Infections.
Dosage : Adult dose : 500 mg to 2g every 8 or 12 hrs.
Maximum Adult dose : 8g/day.
Paediatric dose : 30–90 mg/kg every 6 – 8 hrs.
Maximum Paediatric dose : 120 mg/ kg/day.
Renally Impaired Patients : After an initial loading dose of 1 to 2 grams, the dose should be halved in patients with estimated creatinine clearance between 10 and 30 mL/mi
Packing : | 1 gm | 1 Vial of 1 gm | | 500 gm | 1 Vial of 500 gm | |
 |
Piperacillin And Tazobactam For Injection 2.25g and 4.5g
 | Indications : -
Appendicitis and Peritonitis -
Uncomplicated and complicated skin and soft tissue infections -
Pelvic inflammatory diseases -
Community acquired pneumonia -
Nosocomial pneumonia due to S. aureus Dosage : Children >12 years and Adults :
Nosocomial pneumonia: I.V. : 4.5 g every 6 hours for 7-14 days.
Severe infections : I.V. : 4.5g every 8 hours or 3/0.375 g every 6 hours for 7-10 days.
Moderate infections : I.M. : 2.25g every 6-8 hours; treatment should be continued for 7-10 days depending on severity of disease.
Paediatric : 112.50mg/kg TID (age 9 months or older).
90mg/kg TID (age 2months - 9months).
Really Impaired Patients : | CrCl (mL/min) | All Indications (except nosocomial pneumonia) | Nosocomial Pneumonia | | >40 mL/min | 3.375g q 6 h | 4.5g every 6 h | | 20-40 mL/min | 2.25g every 6 h | 3.375g every 6 h | | <20 mL/min | 2.25g q 8 h | 2.25g every 6 h | | Hemodialysis | 2.25g every 12 h | 2.25g every 8 h | | CAPD | 2.25g every 12 h | 2.25g every 8 | Packing : | 2.25 g | 10 Vials of 2.25 g | | 4.5 g | 10 Vials of 4.5 g | |
Amphotin - Lip 10mg
Amphotericin B Lipid Complex Injection 10 mg Indications :
-
Empirical therapy for presumed fungal infections. -
Treatment for systemic fungal infections. -
Cryptococcal meningitis in HIV. -
In patients where renal impairment or unacceptable toxicity precludes the use of amphotericin B deoxycholate. -
Treatment of Visceral leishmaniasis.
Dosage : The recommended initial dose of Amphotin-Lip for each indication for adult and pediatric patients is as follows : | Indication | Dose (mg/Kg/day) | | Empirical therapy | 3mg/kg/day | | Systematic Fungal infections | | | Aspergillus | 5 | | Candida | 5 | | Cryptococcus | 5 | | Cryptococcal Maningitis in HIV infected Patients | 6mg/kg/day for approx. 120min. | Doses recommended for visceral leishmaniasis are presented below: | Visceral Leishmaniasis | Dose (mg/Kg/Days) | | Immunocompetent Patients | 3.0 (days 1-5) and 3.0 on days 14,21 | | Immunocompromised patients | 4.0 (days 1-5) and 4.0 on days 10, 17, 24, 31, 38 |
Dosage Adjustment
Renal Impairment : Not necessary with renal impairment if decreased renal function is due to amphotericin B the daily dose can be adjusted. Hepatic Impairment : Administer with caution. | 
 |
Amphotericin B Lipid Complex Injection 50 Mg

 | Indications :
-
Empirical therapy for presumed fungal infections -
Treatment for confirmed fungal infections -
Treatment of patients with Aspergillus spp., Candida spp. and/or Cryptococcus spp. infections refractory to amphotericin B deoxycholate -
In patients where renal impairment or unacceptable toxicity precludes the use of amphotericin B deoxycholate -
Treatment of Visceral leishmaniasis Dosage
The recommended initial dose of Amphotin-Lip for each indication for adult and pediatric patients is as follows :
| Indications | Dose (Mg/Kg/day) | | Empirical therapy | 2.5 - 3 | | Systematic Fungal infections | | | Aspergillus | 5 | | Candida | 5 | | Cryptococcus | 5 | | Cryptococcal Maningitis in HIV infected Patients | 5 | Doses recommended for visceral leishmaniasis are presented below: | Visceral Leishmaniasis | Dose (mg/Kg/Days) | | Immunocompetent Patients | 3.0 (days 1-5) and 3.0 on days 14,21 | | Immunocompromised patients | 4.0 (days 1-5) and 4.0 on days 10, 17, 24, 31, 38 | Dosage Adjustment
Renal Impairment : Not necessary with renal impairment if decreased renal function is due to amphotericin B the daily dose can be adjusted. Hepatic Impairment : Administer with caution. |
Amphotericin B Lipid Complex Injection 100 mg
Indications : -
Empirical therapy for presumed fungal infections -
Treatment for confirmed fungal infections -
Treatment of patients with Aspergillus spp., Candida spp. and/or Cryptococcus spp. infections refractory to amphotericin B deoxycholate -
In patients where renal impairmentor unacceptable toxicity precludes the use of amphotericin B deoxycholate -
Treatment of Visceral leishmaniasis Dosage The recommended initial dose of Amphotin-Lip for each indication for adult and pediatric patients is as follows : | Indications | Dose (Mg/Kg/day) | | Empirical therapy | 2.5 - 3 | | Systematic Fungal infections | | | Aspergillus | 5 | | Candida | 5 | | Cryptococcus | 5 | | Cryptococcal Maningitis in HIV infected Patients | 5 | Doses recommended for visceral leishmaniasis are presented below: | Visceral Leishmaniasis | Dose (mg/Kg/Days) | | Immunocompetent Patients | 3.0 (days 1-5) and 3.0 on days 14,21 | | Immunocompromised patients | 4.0 (days 1-5) and 4.0 on days 10, 17, 24, 31, 38 | Dosage Adjustment
Renal Impairment : Not necessary with renal impairment if decreased renal function is due to amphotericin B the daily dose can be adjusted. Hepatic Impairment : Administer with caution. | 
 |
Cefoprim 250mg

 | Cefuroxime Axetil Tablets USP 250 mg
Indications :
- Pharyngitis / Tonsilitis
- Acute Bacterial Otitis Media
- Acute Bacterial Maxillary Sinusitis
- Acute Bacterial Exacerdation of Chronic Bronchitis & Secondary Bacterial Infection of Acute Bronchitis
- Uncomplicated Urinary Tract Infections
- Uncomplicated Skin & Soft Tissue Infections
- Bone & Joint Infections due to S.aureus
- Uncomplicated gonorrhea
- Early Lyme Disease
Dosage Oral : 250 mg to 500 mg BID for 10 days. Uncomplicated Gonorrhea : 1gm OD Paediatric : 30 - 100mg/kg/day BID / QID.
Renally Impaired Patients :
| CrCl (ml/min) | Recommended Dosage | | >10 | No changes | | <10 | 250mg | |
Cefoprim (Cefuroxime Axetil Tablets USP 500 mg)
Indications :
-
Upper Respiratory Tract Infections -
Urinary Tract Infections -
Skin & Soft Tissue Infections -
Bone & Joint Infections due to S.aureus
Dosage :
Adult :
Parenteral : 750 mg to 1.5 g every 8 hours for 5 to 10 days.
Oral : 250 mg to 500 mg BID for 10 days.
Paediatric : 30 - 100mg/kg/day BID / QID.
Renally Impaired Patients :
| CrCl (ml/min) | Recommended Dosage | | >10 | No changes | | <10 | Gives 250mg 24 hr | | 
 |
Cefoprim 750mg

 | (Cefuroxime Sodium For Injection USP 750 mg)
Indications :
Dosage :
Adult :
Parenteral : 750 mg to 1.5 g every 8 hours for 5 to 10 days.
Maximum Dose : 3gm every 8 hrs.
Paediatric : 50 - 100mg/kg/day TID / QID.
Renally Impaired Patients :
| CrCl (ml/min) | Recommended Dosage | | >20 | No changes | | 10 -20 | 750mg BID | |
Cefoprim (Cefuroxime Sodium For Injection USP 1.5 g)
Indications :
-
Upper Respiratory Tract Infections -
Urinary Tract Infections -
Skin & Soft Tissue Infections -
Bone & Joint Infections due to S.aureus
Dosage :
Adult :
Parenteral : 750 mg to 1.5 g every 8 hours for 5 to 10 days.
Oral : 250 mg to 500 mg BID for 10 days.
Paediatric : 30 - 100mg/kg/day BID / QID.
Renally Impaired Patients :
| CrCl (ml/min) | Recommended Dosage | | >10 | No changes | | <10 | Gives 250mg 24 hr | | 
 |
Clavox 1.2g

 | (Amoxicillin And Clavulanate Potassium Injection USP 1.2 g) Indications :
-
Lower Respiratory Tract Infections -
Upper Respiratory Tract Infections -
Skin and Soft Tissue Infections -
Genito Urinary Tract Infections
Dosage :
Intravenous Dosage : 2 Vial 0.6 g or 1 Vial of 1.2 g 6-8 hourly.
Pediatric : 30 mg /kg in divided dose.
Renally Impaired Patients :
| CrCl (ml/min) | Recommended Dosage | | >30 | No changes | | 10-30 | 1.2g injection initially then 600mg 12 hourly. | | <10 | 1.2g injection initially then 600mg 12 Daily. | |
Clavox
Clavox (Amoxicillin And Clavulanate Potassium Injection USP 0.6 g) Indications :
-
Lower Respiratory Tract Infections -
Upper Respiratory Tract Infections -
Skin and Soft Tissue Infections -
Urinary Tract Infections
Dosage : Intravenous Dosage : 2 Vial 0.6 g or 1 Vial of 1.2 g 6-8 hourly.
Pediatric : 30 mg /kg in divided dose.
Renally Impaired Patients :
| CrCl (ml/min) | Recommended Dosage | | >30 | No changes | | 10-30 | One 375mg table or one 625mg tablet 12 hourly | | <10 | Not more than one 375mg table 12 hourly, 625mg tables are not recommended | | 
 |
Clinzucia 600mg

 | (Clindamycin 600mg Amp.)
Indications :
- Serious infection caused by susceptible strains of streptococci, pneumocci & staphylococci.
- Lower respiratory infections including bronchitis, pneumonia, emphyema and lung abscess.
- Bone and joint infections including staphylococcal osteomyelitis and septic arthritis.
- Pelvic infections including endometritis, cellulitis, vaginal cuff infection, tubo-ovarian abscesses, salpingitis and pelvic inflammatory disease .
- Intra-abdominal infections including peritonitis, liver abscess , abdominal
abscess & biliary tract infection . - Septicemia and endocarditis.
- Skin and soft tissue infections including acne, furuncles, cellulitis, impetigo, abscesses, and wound infections.
Dosage : The recommended dosages are :
Clinzucia Injection : Adults : Serious infections : 600-1200mg/day in 2, 3 or 4 equal doses either IM or IV administration.
More Severe Infection : 1200 -2700 mg/day in 2,3 or 4 equal doses (IM or IV) Neonates : 15 to 20mg/kg/day in 3 to 4 equal doses. Pediatric Patients : 20 to 40mg/kg/day in 3 or 4 equal doses either IM or IV administration. |
Clinzucia 150mg
(Clindamycin 150mg Capsules)
Indications :
- Serious infection caused by susceptible strains of streptococci, pneumocci & staphylococci.
- Lower respiratory infections including bronchitis, pneumonia, emphyema and lung abscess.
- Bone and joint infections including staphylococcal osteomyelitis and septic arthritis.
- Pelvic infections including endometritis, cellulitis, vaginal cuff infection, tubo-ovarian abscesses, salpingitis and pelvic inflammatory disease .
- Intra-abdominal infections including peritonitis, liver abscess, abdominal abscess & biliary tract infection .
- Septicemia and endocarditis.
- Skin and soft tissue infections including acne, furuncles, cellulitis, impetigo, abscesses, and wound infections.
Dosage : The recommended dosages are :
Clinzucia Capsules
Adults
Severe infections : 150 to 300mg every 6 hours.
More severe infections: 300mg to 450 mg every 6 hours.
Pediatrics :
Severe infections : 8 to 16mg/kg/day divided into three or four equal doses. More severe : 16 to 20mg/kg/day divided into three or four equal doses. | 
 |
Clinzucia (Clindamycin 300mg Injection)

 | Indications :
-
Upper respiratory infections including tonsillitis, pharyngitis, sinusitis, otitis media and scarlet fever. -
Lower respiratory infections including bronchitis, pneumonia, emphyema and lung abscess. -
Bone and joint infections including staphylococcal osteomyelitis and septic arthritis. -
Pelvic infections including endometritis, cellulitis, vaginal cuff infection, tubo-ovarian abscesses, salpingitis and pelvic inflammatory disease . -
Intra-abdominal infections including peritonitis, liver abscess , abdominal abscess & biliary tract infection . -
Septicemia and endocarditis. -
Dental infections such as periodental abscess and periodonitis. -
As an alternative therapy when used in combination with quinine or amodiaquine for the treatment of multi-drug resistant Plasmodium falciparum infection. -
Skin and soft tissue infections including acne, furuncles, cellulitis, impetigo, abscesses, and wound infections.
Dosage : The recommended dosages are : Clinzucia Capsules.
Adults :
Moderate infections : 50 to 300mg every 6 hours.
More severe infections: 300mg to 450 mg every 6 hours.
Paediatrics :
Moderate infections : 8 to 12mg/kg/day divided into three or four equal doses.
More severe : 16 to 20mg/kg/day divided into three or four equal infections doses.
Clinzucia Injection
Adults :
Serious infections : 600-1200mg/day in 2, 3 or 4 equal doses either IM or IV administration.
Neonates : 15 to 20mg/kg/day in 3 to 4 equal doses.
Pediatric Patients : 20 to 40mg/kg/day in 3 or 4 equal doses either IM or IV administration. |
Clinzucia (Clindamycin 300mg Cap.)
Indications :
-
Upper respiratory infections including tonsillitis, pharyngitis, sinusitis, otitis media and scarlet fever. -
Lower respiratory infections including bronchitis, pneumonia, emphyema and lung abscess. -
Bone and joint infections including staphylococcal osteomyelitis and septic arthritis. -
Pelvic infections including endometritis, cellulitis, vaginal cuff infection, tubo-ovarian abscesses, salpingitis and pelvic inflammatory disease . -
Intra-abdominal infections including peritonitis, liver abscess , abdominal abscess & biliary tract infection . -
Septicemia and endocarditis. -
Dental infections such as periodental abscess and periodonitis. -
As an alternative therapy when used in combination with quinine or amodiaquine for the treatment of multi-drug resistant Plasmodium falciparum infection. -
Skin and soft tissue infections including acne, furuncles, cellulitis, impetigo, abscesses, and wound infections.
Dosage : The recommended dosages are :
Clinzucia Capsules
Adults :
Moderate infections : 50 to 300mg every 6 hours.
More severe infections: 300mg to 450 mg every 6 hours.
Paediatrics :
Moderate infections : 8 to 12mg/kg/day divided into three or four equal doses.
More severe : 16 to 20mg/kg/day divided into three or four equal infections doses.
Clinzucia Injection
Adults :
Serious infections : 600-1200mg/day in 2, 3 or 4 equal doses either IM or IV administration.
Neonates : 15 to 20mg/kg/day in 3 to 4 equal doses.
Pediatric Patients : 20 to 40mg/kg/day in 3 or 4 equal doses either IM or IV administration. | 
 |
Egytig 50mg

 | (Tigecycline 50mg Vial)
Indications :
-
Complicated Skin & Skin Structure infections. -
Complicated Intra-Abdominal infections. -
Community – Acquired Bacterial Pneumonia.
Dosage : Initial dose of 100mg, followed by 50mg every 12 hrs. IV should be administered approx. 30-60 mins. every 12 hrs.
Renal Insufficiency : No dosage adjustment required.
Hepatic Insufficiency : No dosages adjustment required in mild & moderate hepatic impairment (Child Pugh A and Child Pugh B). In patient with severe hepatic impairment (Child Pugh C) should be 100 mg followed by a reduced maintenance dose of 25 mg every 12 hours. |
Epime 1g
(Cefepime 1g Vial)
Indications :
-
Pneumonia (S. pneumoniae, P. aeruginosa, K. pneumoniae, or Enterobacter species). -
Empiric Therapy for Febrile Neutropenia. -
Uncomplicated & Complicated Urinary Tract Infections including pyelonephritis. -
Uncomplicated Skin and Skin Structure Infections (S. aureus and S. pyogenes). -
Intra-abdominal Infections (E. coli, viridans group streptococci, P. aeruginosa, K. pneumoniae, Enterobacter species, or B. fragilis).
Dosage : Initial dose of 100mg, followed by 50mg every 12 hrs.
Adults: IV: 1-2g every 8-12 hrs; IM: 0.5-1g every 12 hrs
Children: IM, IV: 50 mg/kg/dose every 8-12 hours (not to exceed maximum adult dosing)
Renal: Dosages adjustment required according to CrCl. | 
 |
Epime - TZ (Cefepime 1000 mg - Tazobactam 125 mg)

 | Indications and Dosage :
| Sl No. | Site & Type of Infection in Adults | Dose | Frequency | Duration | | 1 | Pneumonia (Mild to Moderate) | 1.2 g iv | 12 hrly | 10 | | 2 | Empiric Therapy for febrile Neutropenia | 2 g iv | 8 hrly | 7 | | 3 | Mild to moderate uncomplicated & complicated Urinary tract Infections | 0.5 – 1g iv/M | 12 hrly | 7-10 | | 4 | Sever complicated Urinary tract Infections | 2 g iv | 12 hrly | 10 | | 5 | Mild to moderate Skin and skin structural Infections | 2 g iv | 12 hrly | 10 | | 6 | Intra-abdominal Infections | 2 g iv | 12 hrly | 7-10 | |
Forzid 1g
(Ceftazidime For Injection USP 1g)
Indications :
Dosage :
Adult Dose : 1g IV or IM daily in divided dose every 8 or 12 hrs.
Paediatric Dose : 30 to 50 mg/kg daily every 8 hours.
Renally Impaired Patients :
| CrCl (ml/min) | Recommended Dosage | | 50 - 31 | 1.0 g every 12 grs | | 30 - 16 | 1.0 g every 24 hrs | | 15 – 6 | 0.5 g every 24 hrs | | <5 | 0.5 g every 48 hrs | | 
 |
Forzid (Ceftazidime For Injection USP 2.0 G)

 | Indications : -
Infections primarily caused by Pseudomonas sp. -
Lower respiratory tract infections (including pneumonia) -
Urinary Tract Infections -
Bacterial septicemia -
As a prophylactic agent in the surgical infections -
Bone & Joint infections -
Febrile Neutropenia -
CNS infections
Dosage :
Adult Dose : 1 to 6 g daily in divided dose every 8 or 12 hrs.
Paediatric Dose : 30 to 100 mg/kg daily in 2 or 3 divided doses.
Renally Impaired Patients : | CrCl (ml/min) | Recommended Dosage | | 50 - 31 | 1.0 g every 12 grs | | 30 - 16 | 1.0 g every 24 hrs | | 15 – 6 | 0.5 g every 24 hrs | | 5 | 0.5 g every 48 hrs | |
Heprotec 5g
(L-Ornithine-L-Aspartate Granules 3g)
Indications :
Dosage : Sachets :1-2 Sachet (Dissolve in a glass of water) 3 Times a day
Renally Impaired Patients : Not known, administer with caution. Packing : 10 Sachets of 5g | 
 |
Heprotec 5g / 10ml

 | (L-Ornithine-L-Aspartate Infusion 5 g/10 ml)
Indications : - Encephalopathy
- Acute Liver Failure
- Hyperammonemia due to liver cirrhosis, hepatitis, Fatty liver
- Jaundice
Dosage : Injection Adult : 4 amp. x 4 days or 8 amp. x 4 days and then 4 amp. x 3 days.
Maximum infusion rate : 5g / hr.
Renally Impaired Patients : Not known, administer with caution. Packing : 5 Ampoules of 10 ml |
Heprotec 150mg
(L-Ornithine-L-Aspartate + Pancreatin Tablets 150 mg)
Indications :
Dosage : Tablets : 1-2 tablets 3 times a day for 3 months. Renally Impaired Patients : Not known, administer with caution. Packing : 10 Strips of 10 Tablets | 
 |
Kephazon 2GM
 | (Cefoperazone Sodium 2gm)
Indications : Dosage : Adult : 2-4 gm / day in 2 equally divided doses. Paediatric : 50-200 mg/ kg/ day in 2 equally divided doses.
Renally Impaired Patients : No dosage adjustment with normal hepatic function. If hepatic disease and severe renal failure (CrCl<10) than max. dose ranges from 1-2g/day. Packing : 1 Vial of 2gm |
Kephazon 1GM
(Cefoperazone Sodium 1gm) Indications : Dosage : Adult : 2-4 gm / day in 2 equally divided doses. Paediatric : 50-200 mg/ kg/ day in 2 equally divided doses.
Renally Impaired Patients : No dosage adjustment with normal hepatic function. If hepatic disease and severe renal failure (CrCl<10) than max. dose ranges from 1-2g/day. Packing : 1 Vial of 1gm |
 |
Kephazon-S 2GM
 | (Cefoperazone And Sulbactam 2gm)
Indications : - Bacterial septicaemia
- Respiratory Tract Infection
- Urinary Tract Infection
- Peritonitis
- Skin and Soft Tissue Infections
- Pelvic Inflammatory disease.
Dosage : Adult : 2-4 gm / day in 2 equally divided doses. Paediatric : 50-200 mg/ kg/ day in 2 equally divided doses. Renally Impaired Patients : No dosage adjustment required. Packing : 1 Vial of 2g |
Kephazon-S (Cefoperazone And Sulbactam 1G)
Indications : Dosage : Adult : 2-4 gm / day in 2 equally divided doses. Paediatric : 50-200 mg/ kg/ day in 2 equally divided doses. Renally Impaired Patients : No dosage adjustment required. Packing : 1 Vial of 1g |
 |
Kephazon-S Forte 3GM
 | (Cefoperazone And Sulbactam For Injection 3gm) Indications : -
Respiratory Tract Infections -
Peritonitis and other intra-abdominal infections -
Bacterial septicaemia -
Skin and Soft tissue infections -
Prophylaxis in Pre/Post Operative Infections Dosage : Adult : 1.5-3g every 12 hours in equally divided doses. Pediatric : 30-60 mg/kg/day every 6 to 12 hours in equally divided doses. Renally Impaired Patients : Dosage adjustment required. Packing : 10 Vials of 3g |
Kephazon-S Forte 1.5G
(Cefoperazone And Sulbactam For Injection 1.5g) Indications : -
Respiratory Tract Infections -
Peritonitis and other intra-abdominal infections -
Bacterial septicaemia -
Skin and Soft tissue infections -
Prophylaxis in Pre/Post Operative Infections Dosage : Adult : 1.5-3g every 12 hours in equally divided doses. Pediatric : 30-60 mg/kg/day every 6 to 12 hours in equally divided doses. Renally Impaired Patients : Dosage adjustment required. Packing : 10 Vials of 1.5g |
 |
Laczucia 200MG
 | (Lactulose 200mg Bottles)
Indications : Dosage :
Constipation
Adult : 15-30 ml may be increased to 60ml daily.
Paediatric : 5-15 ml 1-2 times a day. Dose in Portal Systemic Encephalopathy : Start with 30-45 ml 3-4 times daily.
Renally Impaired Patients : No dosage adjustment required. Packing : 1 Bottle of 200 ml |
Laczucia (Lactulose 100MG Bottles)
Indications : Dosage : Adult : 15-30 ml3-4 times a day. Paediatric : 5-15 ml1-2 times a day. Dose in Hepatic Encephalopathy : Start with 30-40 ml over every 1 hour. Renally Impaired Patients : No dosage adjustment required. Packing : 1 Bottle of 100 ml. |
 |
Menem 1G
 | (Meropenem For Injection USP 1g)
Indications : - Intra abdominal infections.
- Bacterial Meningitis.
- Complicated SSTI
- Nosocomial pneumonia.
Dosage :
Adult Dose : 500mg - 1g IV TID. Pediatric Dose : 10-20mg/kg IV every 8 hrs. Dosage Adjustment : Renal Impairment : Required.
Hepatic Impairment : Not necessary.
Packing : 10 Vials of 1g |
Menem (Meropenem For Injection USP 500 MG)
Indications : Dosage : Adult Dose : 500mg - 1g IV TID. Pediatric Dose : 10-20mg/kg IV every 8 hrs. Dosage Adjustment : Renal Impairment : Required. Hepatic Impairment : Not necessary. Packing : 10 Vials of 500 mg
|
 |
Mucosys 600MG
 | (Acetylcysteine 600mg Tablets)
Indications : Adjuvant therapy with abnormal and viscous mucus secretions in : -
Chronic Bronchopulmonary Diseases like: Chronic emphysema, Emphysema with Bronchitis, Chronic asthmatic Bronchitis, Tuberculosis, Bronchiectasis, Primary Amyloidosis of Lungs. -
Acute Bronchopulmonary Diseases like: Pneumonia, Bronchitis, Tracheo-bronchitis Pulmonary complications of Cystic fibrosis & those associated with surgery. -
Post tracheostomy care. -
During Anaesthesia. -
Pos traumatic chest conditions. -
Atelactasis due to mucus obstruction. Dosage : Usual adult and adolescent dose : As Mucolytic : Adult Dose : 600mg OD Pediatric Dose : 200mg OD
Prevention of Acute Renal failure associated with radiographic contrast media : 600mg BID. Renally Impaired Patients : Caution is necessary.
Packing : 10 Strips of 4 Tablets. |
Mucosys 5ML
(Acetylcysteine 20% Solution USP 5ml)
Indications : Adjuvant therapy with abnormal and viscous mucus secretions in : -
Chronic Bronchopulmonary Diseases like: Chronic emphysema, Emphysema with Bronchitis, Chronic asthmatic Bronchitis, Tuberculosis, Bronchiectasis, Primary Amyloidosis of Lungs. -
Acute Bronchopulmonary Diseases like: Pneumonia, Bronchitis, Tracheo-bronchitis Pulmonary complications of Cystic fibrosis & those associated with surgery. -
Post tracheostomy care. -
During Anaesthesia. -
Pos traumatic chest conditions. -
Atelactasis due to mucus obstruction. -
Chemoprevention and treatment.
Overdosage of acetaminophen. Dosage : Usual adult and adolescent dose :
As Mucolytic : Administration can be by nebulization of 1 to 10 ml of the 20% solution or 2 to 20 ml of the 10% solution may be given every 2 to 6 hours. When used by direct instillation, 1 to 2 ml of 20% solution may be given as often as every hour.
As antidote for acetaminophen overdose : Oral, 140 mg per kg of body weight initially, followed by 70 mg per kg of body weight every four hours for 17 additional doses Oral administration requires dilution of the 20% solution with diet cola, or other diet soft drinks, to a final concentration of 5%. Cancer : 500-600mg TID
Cancer Prevention : 600-100mg OD
Renally Impaired Patients : Caution is necessary. Packing : 10 Packs of 5 Ampoules of 5 ml |
 |
Mucosys 2ML
 | (Acetylcysteine 20% Solution USP 2 ml)
Indications :
Adjuvant therapy with abnormal and viscous mucus secretions in : -
Chronic Bronchopulmonary Diseases like: Chronic emphysema, Emphysema with Bronchitis, Chronic asthmatic Bronchitis, Tuberculosis, Bronchiectasis, Primary Amyloidosis of Lungs. -
Acute Bronchopulmonary Diseases like: Pneumonia, Bronchitis, Tracheo-bronchitis Pulmonary complications of Cystic fibrosis & those associated with surgery. -
Post tracheostomy care. -
During Anaesthesia. -
Pos traumatic chest conditions. -
Atelactasis due to mucus obstruction. -
Chemoprevention and treatment. Dosage : Usual adult and adolescent dose : As Mucolytic : Administration can be by nebulization of 1 to 10 mlof the 20% solution or 2 to 20 mlof the 10% solution may be given every 2 to 6 hours. When used by direct instillation, 1 to 2 ml of a 10% to 20% solution may be given as often as every hour. As antidote for acetaminophen overdose : Oral, 140 mg per kg of body weight initially, followed by 70 mg per kg of body weight every four hours for 17 additional doses Oral administration requires dilution of the 20% solution with diet cola, or other diet soft drinks, to a final concentration of 5%. Cancer : 500-600mg TID
Cancer Prevention : 600-100mg OD
Renally Impaired Patients : Caution is necessary. Packing : 10 Packs of 2 Ampoules of 2 ml. |
Noralin 2ML (2MG/ML)
(Sterile Noradrenalin Concentrate BP 2mg/ml)
Indications : Dosage : Adult Dose : The usual initial dose is 8-12mcg/min. Average maintenance dose is 2mcg-4mcg/min. Pediatric Dose : The usual dose is 1-2 mcg/kg/min. or 2 mcg/m2/min.
Renally Impaired Patients : Not known, administer with caution. Packing : 10 Packs of 2 Ampoules of 2 ml. |
 |
SOL - U- PRED (Methylprednisolone Sodium Succinate 1G Vial)
 | Indications : Neurological Conditions Multiple Sclerosis, Spinal Cord Injury, Cerebral Injury Nephrological Conditions Glomerular Nephritis, Lupus Nephritis Organ Transplant Rheumatic Conditions Acute Gouty Arthritis, Acute Rheumatic Carditis, Psoriatic Arthritis, Rheumatoid Arthritis Acute Respiratory Distress Syndrome (ARDS) Dosage : May be administered by IV or IM injection or by IV infusion. The preferred method for initial emergency is IV injection.
Usual Doses : 30mg/kg administered IV over atleast 30 minutes. This dose may be repeated every 4-6 hour for 48 hours.
Initial Doses : 10-40mg IV over a period of several minutes. The larger doses may be required for short term management of severe, acute conditions.
In Multiple Sclerosis : 200mg for a week followed by 80mg every other day for one month.
In Renal Transplantation : For induction of Immunosuppression : Start with 80-160mg OD for three days followed by oral therapy. In treatment of acute rejection : 500 mg upon diagnosis, followed by 500 mg OD for two days.
Acute Spinal Cord Injury : 30 mg/kg bolus followed by 5.4 mg/kg bolus for 24-48 hours.
Prevention of ARDS and Fat Embolism syndrome : 30 mg/kg body weight can be repeated after 6 hours. Packing : 1 Vial of 1g |
Solupred
SOL - U- PRED (Methylprednisolone Sodium Succinate 500MG Vial) Indications : Neurological Conditions Multiple Sclerosis, Spinal Cord Injury, Cerebral Injury Nephrological Conditions Glomerular Nephritis, Lupus Nephritis Organ Transplant Rheumatic Conditions Acute Gouty Arthritis, Acute Rheumatic Carditis, Psoriatic Arthritis, Rheumatoid Arthritis Acute Respiratory Distress Syndrome (ARDS) Dosage : May be administered by IV or IM injection or by IV infusion. The preferred method for initial emergency is IV injection.
Usual Doses : 30mg/kg administered IV over atleast 30 minutes. This dose may be repeated every 4-6 hour for 48 hours.
Initial Doses : 10-40mg IV over a period of several minutes. The larger doses may be required for short term management of severe, acute conditions.
In Multiple Sclerosis : 200mg for a week followed by 80mg every other day for one month.
In Renal Transplantation : For induction of Immunosuppression : Start with 80-160mg OD for three days followed by oral therapy. In treatment of acute rejection : 500 mg upon diagnosis, followed by 500 mg OD for two days.
Acute Spinal Cord Injury : 30 mg/kg bolus followed by 5.4 mg/kg bolus for 24-48 hours.
Prevention of ARDS and Fat Embolism syndrome : 30 mg/kg body weight can be repeated after 6 hours. Packing : 1 Vial of 500mg |
 |
Tecazi 500MG
 | (Azithromycin 500mg Injection)
Indications : Dosage : Adult : | Infections | Recommended Dose/Duration of Therapy | | Community-acquired pneumonia (mild severity) | I.V: 500 mg IV as a single dose for 2 days, followed by 500 mg once daily oral dose for 7 – 10 days | | Pelvic inflammatory disease | 500mg IV as a single dose for 1 – 2 days, followed by 250 mg once daily oral dose for 7 days | | |
| | | | | | | | | | | | | | | | | |
| Packing : 1 Vial of 500mg |
Tecazi 500mg
(Azithromycin 500mg Tablets)
Indications : Adults: -
Community – acquired pneumonia -
Acute Exacerbation of Chronic Obstructive Pulmonary Diseas -
Pharyngitis/Tonsillitis -
Uncomplicated Skin Infection -
Urethritis, Cervicitis, Pelvic Inflammatory Disease and Genital Ulcers Children: Dosage : Adult : | Infections | Recommended Dose/Duration of Therapy | | Community-acquired pneumonia (mild severity) | Oral:500 mg as a single dose on Day 1, followed by250 mg once daily on Days 2 to 5 I.V: 500 mg IV as a single dose for 2 days, followed by 500 mg once daily oral dose for 7 – 10 days | | Pharyngitis/tonsillitis (second line therapy) / Skin/skin structure (uncomplicated) | 500 mg as a single dose on Day 1, followed by 250 mg once daily on Days 2 to 5 | | Acute bacterial exacerbations of chronic obstructive pulmonary disease (mild to moderate) | 500 mg OD X 3 days or 500 mg as a single dose on day 1, followed 250 mg once daily on days 2 to 5 | | | | | Genital ulcer didease (chancroid) | Single 1 gram dose | | Non gonoccocal urethritis and cervicitis | Single 1 gram dose | | Gonococcal urethritis & Cetvicitis | Singe 2 gram dose | | Pelvic inflammatory disease | 500mg IV as a single dose for 1 – 2 days, followed by 250 mg once daily oral dose for 7 days. | | | | Packing : 1 Strip of 3 Tabs |
 |
Tecazi 250MG
 | (Azithromycin 250mg Tablets)
Indications : Adults: -
Community – acquired pneumonia -
Acute Exacerbation of Chronic Obstructive Pulmonary Diseas -
Pharyngitis / Tonsillitis -
Uncomplicated Skin Infection -
Urethritis, Cervicitis, Pelvic Inflammatory Disease and Genital Ulcers -
Cystic Fibrosis Children: Dosage : Adult : | Infections | Recommended Dose/Duration of Therapy | | Community-acquired pneumonia (mild severity) | Oral:500 mg as a single dose on Day 1, followed by250 mg once daily on Days 2 to 5 I.V: 500 mg IV as a single dose for 2 days, followed by 500 mg once daily oral dose for 7 – 10 days | | Pharyngitis/tonsillitis (second line therapy) / Skin/skin structure (uncomplicated) | 500 mg as a single dose on Day 1, followed by 250 mg once daily on Days 2 to 5 | | Acute bacterial exacerbations of chronic obstructive pulmonary disease (mild to moderate) | 500 mg OD X 3 days or 500 mg as a single dose on day 1, followed 250 mg once daily on days 2 to 5 | | Acute bacterial sinsitis | 500 mf OD X 3 days | | Genital ulcer disease (chancroid) | Single 1 gram dose | | Non gonoccocal urethritis and cervicitis | Single 1 gram dose | | Gonococcal urethritis & Cetvicitis | Singe 2 gram dose | | Cystic fibrosis | 250 mg or 500mg three time a week for 12 months | | Pelvic inflammatory disease | 500mg IV as a single dose for 1 – 2 days, followed by 250 mg once daily oral dose for 7 da | Packing : 1 Strip of 6 Tabs. |
Tecoplan 400MG
(Teicoplanin For Injection 400mg Lyophilized )
Indications : -
Osteomyelitis - Endocarditis
- UTI
- Peritonitis Associated with chronic
ambulatory Peritoneal dialysis (CAPD) - Respiratory Infections
Dosage : Adult Dose : Acute or chronic osteomyelitis : 400mg IV every 12 hr for 3 doses then 400 mg once daily as maintenance dosage.
Pediatric Patients: (Children aged 2 months - 16 years) For severe infection and infection in neutropenic patients : 10 mg /kg every 12 hr for 3 dosages and then 10 mg / kg as a single dose once daily.
For moderate infections : 10 mg / kg IV every 12 hr for first three doses thereafter 6 mg / kg as IV or IM as single dose once daily.
Renally Impaired Patients : For patients with impaired renal function, reduction of dosage is not required until the fourth day of treatment. Packing : 5 Vials of 400 mg |
 |
Tecoplan (Teicoplanin For Injection 200 MG Lyophilized)
 | Indications : Dosage : Adult dose : Septicaemia/Bacteraemia/ Acute or chronic osteomyelitis : 400mg IV every 12 hr for 3 doses then 400 mg once daily as maintenance dosage.
Septic Arthritis : 800mg IV every 12 hr for 3 dosages then 800mg once daily as maintenance dosage.
Pediatric patients : (Children aged 2 months - 16 years) For severe infection and infection in neutropenic patients : 10 mg /kg every 12 hr for 3 dosages and then 10 mg / kg as a single dose once daily.
For moderate infections : 10 mg / kg IV every 12 hr for first three doses thereafter 6 mg / kg as IV or IM as single dose once daily.
Renally Impaired Patients : For patients with impaired renal function, reduction of dosage is not required until the fourth day of treatment. Packing : 5 Vials of 200 mg |
Ticarnic
(Ticarcillin and clavulanic acid for injection USP 3.1 g) Indications : -
Septicemia (including bacteremia) -
Lower Respiratory Tract Infections -
Bone and Joint Infections -
Skin and Skin Structure Infections -
Urinary Tract Infections -
Gynecological Infections - Intra-abdominal Infections (Peritonitis
- Mixed Infections
Dosage : Adults 60 kg or greater : 3.1 g every 4 to 6 hours.
Adults Less than 60kg : 200 to 300 mg/kg/day (based on ticarcillin content) every 4 to 6 hours.
Infants & Children : Non U.T.I. Severe : 50mg/kg every 4 hours.
Mild-moderate : 50mg/kg every 6 hours.
U.T.I. Complicated : 50mg/kg every 4 hours.
Uncomplicated : 50mg/kg every 6 hours.
Renally Impaired Patients : Dosage adjustments required. Packing : 10 Vials of 3.1 g |
 |
Tocin 80MG
 | (Tobramycin Injection USP 80 mg)
Indications : -
Lower Respiratory Tract Infections -
Complicated and recurrent UTIs -
Intra abdominal infections -
Septicemia - Serious CNS infections
- Skin, bone & skin structure infections.
-
Prophylaxis in Surgery Dosage : Adult dose: 3-5 mg/kg daily in 3 or 4 divided doses.
Paediatric dose : 6-7.5 mg/kg in 3 or 4 divided doses.
Renally Impaired Patients: | CrCl(ml/min) | Recommended dose | | >60 | Give every 8h | | 40-60 | Give every 12h | | 20-40 | Give every 24h | | 10-20 | Give every 48h | | < 10 | Give every 48 - | High-dose (once daily) therapy: | CrCl(ml/min) | Recommended dose | | >60 | Usual dose | | <60 | Extend interval based on serum level determinations. | Packing : 25 Vials of 80 mg/2 ml |
U-Aminos (Dialysis Sparing Amino Acid Tablets)
Indications : Dosage : 2 tablets T.D.S.
The tablets should be swallowed as whole and taken with 3-5 meals evenly distributed over the day. Packing : 1 Strip of 10 Tabs |
 |
Unicalcin 50 IU
 | (Calcitonin Salmon Nasal Solution USP 3.7 ml 30 MD) Indications : Post Menopausal Osteoporosis Dosage : One spray (200 IU) per day administered intranasally, alternating nostrils daily.
Renally Impaired Patients : No dosage adjustment required. Packing : 10 Spray Bottles of 3.7 ml Solution. |
Unicalcin 100 IU
(Calcitonin Salmon Injection USP 100 IU)
Indications : Dosage : Osteoporosis/Post Menopausal Osteoprosis : 100 IU once a day on alternate days.
Paget's Disease : Initial Dose : 100 units per day
Maintenance Dose : 50 IU once a day on alternate days.
Hypercalcemia : 4 IU/kg body wt I.V. every 12 hrs.
Maximum Dose : 8 IU/kg every 6 hrs.
Renally Impaired Patients : No dosage adjustment required. Packing : 5 Ampoules of 100 IU/1 ml |
 |
Unicalcin (Calcitonin Salmon Injection USP 50 IU)
 | Indications : -
Paget's Disease (Osteitis deformans) -
Hypercalcemia 2 -
Post Menopausal Osteoporosis -
Metastatic Bone Pain -
Reflex Sympathetic Dystrophy -
Bone pain associated with osteolysis & osteopenia -
Adjuvant therapy for acute pancreatitis Dosage : Osteoporosis/Post Menopausal Osteoprosis : 100 IU once a day on alternate days.
Paget's Disease : 50 IU once a day on alternate days.
Hypercalcemia : 4-8 IU/kg body wt I.V. every 12 hrs.
Renally Impaired Patients : No dosage adjustment required. Packing : 5 Ampoules of 50 IU/1 ml |
Unipol-B 500000 Units
(Polymyxin B For Injection USP 500000 Units)
Indications : Pseudomonal infections : Infections of urinary tract, meninges & bloodstream infections caused due to P. aeruginosa.
Serious infections from H. influenzae, E. coli, Enterobacter aerogenes, Klebsiella pneumoniae. Dosage : IV :
Adult & Children : 25,000 units/kg/day in divided doses every 12 hours.
Infants : Upto 25,000 units/kg/day (Intrathecal).
IM :
Adult & Children : 25,000–30,000 units/kg daily administered in divided doses at 4 to 6 hour intervals.
Infants : Up to 40,000 units/kg daily.
Intrathecal Dose incase of P. aeruginosa meningitis. Packing : 10 Vials of 500000 Units |
 |
Unitrax-s (Ceftriaxone And Sulbactam For Injection 1.5 G)
 | Indications : Dosage : Adult Dose: 1 to 2 g once a day.
Maximum Dose : 4g / day.
Paediatric Dose : 50 to 75 mg/kg in divided doses.
Maximum Dose : 2g / day.
Renally Impaired Patients : Dosage regimen should be adjusted in patients with marked decrease in renal function (creatinine clearance of < 30ml/min) and to compensate for reduced clearance less than 15ml/min patient should receive a maximum of 500mg of sulbactam every 12 hours (maximum dose 1 gram of sulbactam). Packing : 10 Vials of 1.5 g |
Univir 250MG
(Aciclovir Sodium For Intravenous Infusion BP 250mg)
Indications : Mucosal and cutaneous HSV infections in immuno-compromised patients.
Varicella – Zoster infections (shingles) in immuno-compromised patients.
Herpes Simplex encephalitis. Initial Episodes of herpes genitalis
Dosage :
Adult Dose : 5-10 mg/kg infused at a constant rate over 1 hr every 8 hr for 7-10 days.
Paediatric Dose : 250- 500 mg / m2 infused at a constant rate over 1 hr every 8 hr for 7-10 days.
Renally Impaired Patients : | CrCl(ml/min) | Recommended Dosage | | 25-50 | Extend IV dosing interval to every 12 hours | | 10-24 | Extend IV dosing interval to every 24 hours | | < 10 | Reduce recommended IV dose by 50% and extend dosing interval to every 24hours. | Packing : 5 Vials of 250 mg |
 |
Vancotec CP 500mg
 | (Vancomycin Hydrochloride For Injection USP 500 mg) Indications : Dosage :
Endocarditis : 2gm IV divided as 500mg every 6 hrs.
Pseudomenbranous colitis / Staphylococcal enterocolitis : 500mg-2gm daily given in 3 or 4 divided dose.
Staphylococcal Infections : 2gm IV divided as 500mg every 6 hrs. or 1gm every 12 hrs. Adult Dose : The usual adult dose is the equivalent of 500 mg of vancomycin every 6 hours or 1 g every 12 hours.
Paediatric Dose : 10 - 15 mg/kg every 8 hours. Renally Impaired Patients : | CrCl (ml/min) | Recommended dosage (mg/24h) | | 100 | 1,545 | | 90 | 1,390 | | 80 | 1,235 | | 70 | 1,080 | | 60 | 925 | | 50 | 770 | | 40 | 620 | | 30 | 465 | | 20 | 310 | | 10 | 155 | Packing : 10 Vials of 500 mg. |
Vancotec CP (Vancomycin Hydrochloride For Injection USP 1G)
Indications : Dosage : Adult dose : The usual adult dose is the equivalent of 500 mg of vancomycin every 6 hours or 1 g every 12 hours.
Paediatric dose : 10 - 15 mg/kg every 8 hours. Renally Impaired Patients : | CrCl (ml/min) | Recommended dosage (mg/24h) | | 100 | 1,545 | | 90 | 1,390 | | 80 | 1,235 | | 70 | 1,080 | | 60 | 925 | | 50 | 770 | | 40 | 620 | | 30 | 465 | | 20 | 310 | | 10 | 155 | Packing : 10 Vials of 1g
|
 |
|